GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Balchem Corp (NAS:BCPC) » Definitions » EV-to-EBITDA

BCPC (Balchem) EV-to-EBITDA : 23.39 (As of Jul. 04, 2025)


View and export this data going back to 1986. Start your Free Trial

What is Balchem EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Balchem's enterprise value is $5,540.7 Mil. Balchem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $236.9 Mil. Therefore, Balchem's EV-to-EBITDA for today is 23.39.

The historical rank and industry rank for Balchem's EV-to-EBITDA or its related term are showing as below:

BCPC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 13.97   Med: 22.54   Max: 31.86
Current: 23.39

During the past 13 years, the highest EV-to-EBITDA of Balchem was 31.86. The lowest was 13.97. And the median was 22.54.

BCPC's EV-to-EBITDA is ranked worse than
66.25% of 1280 companies
in the Chemicals industry
Industry Median: 14.36 vs BCPC: 23.39

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-07-04), Balchem's stock price is $165.02. Balchem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $4.170. Therefore, Balchem's PE Ratio (TTM) for today is 39.57.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Balchem EV-to-EBITDA Historical Data

The historical data trend for Balchem's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balchem EV-to-EBITDA Chart

Balchem Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.54 30.91 22.06 23.57 23.64

Balchem Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.76 23.35 26.15 23.64 23.52

Competitive Comparison of Balchem's EV-to-EBITDA

For the Specialty Chemicals subindustry, Balchem's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Balchem's EV-to-EBITDA Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Balchem's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Balchem's EV-to-EBITDA falls into.


;
;

Balchem EV-to-EBITDA Calculation

Balchem's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=5540.672/236.916
=23.39

Balchem's current Enterprise Value is $5,540.7 Mil.
Balchem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $236.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Balchem  (NAS:BCPC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Balchem's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=165.02/4.170
=39.57

Balchem's share price for today is $165.02.
Balchem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.170.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Balchem EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Balchem's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Balchem Business Description

Traded in Other Exchanges
Address
5 Paragon Drive, Montvale, NJ, USA, 07645
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Executives
Van Gunsteren Job Leonard officer: Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
William A. Backus officer: Chief Accounting Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Michael Robert Sestrick officer: Chief Technology Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
David B Fischer director 425 WINTER ROAD, DELAWARE OH 43015
Michael Bent Tignor officer: Chief Human Resources Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Matthew David Wineinger director 3605 GRAND VIEW COURT, ST CHARLES IL 60175
Theodore L Harris director, officer: President and CEO 5200 BLAZER PARKWAY, DUBLIN OH 43017
Olivier Rigaud director CORBION NV, PIET HEINKADE 127, AMSTERDAM P7 1019 GM
Monica Vicente director C/O FRESH DEL MONTE PRODUCE INC., P.O. BOX 149222, CORAL GABLES FL 33114
Frederic Boned officer: SVP/GM, Human Nutri. & Health 5 PARAGON DRIVE, MONTVALE NJ 07645
Hatsuki Miyata officer: General Counsel and Secretary 5 PARAGON DRIVE, MONTVALE NJ 07645
Jonathan Harrison Griffin officer: Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Martin Luther Reid officer: Chief Supply Chain Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Kathleen B Fish director ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
James C Hyde officer: Sr. Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958